24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
About
Newsletter
Contact us
RSS
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Eli Lilly
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
Terms Of Use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
11:20
How Iran’s fate could shape Israel’s economic revival—or ruin
10:32
Will antitrust regulators kill Google’s $32B Wiz deal?
22:04
Google’s $32 billion acquisition of Wiz draws antitrust attention
17:12
Navan to file confidentially for IPO, betting on market reopening
More stories
Buzz
Most popular
Daily
Weekly
1
Intel to cut jobs at Kiryat Gat fab, says it must “position our business for the future”
2
Navan to file confidentially for IPO, betting on market reopening
3
Combat-ready and camera-eyed: The X-Intra drone joins Israel’s arsenal
4
Google’s $32 billion acquisition of Wiz draws antitrust attention
5
Andreessen Horowitz targets elite IDF alumni for startup accelerator
More news
Eli Lilly
2 stories about Eli Lilly
1,000% stock increase: The story behind Eli Lilly’s pharmaceutical dominance
14.08.24
|
Viki Auslender
Beating second-quarter forecasts mainly due to its weight loss and diabetes drugs, Eli Lilly, the company aspiring to be worth a trillion dollars, has invested heavily in innovative developments, becoming the pharmaceutical manufacturer with the highest market value in the world.
Eli Lilly Signs Multi-Year Collaboration with Anima Biotech
23.07.18
|
Lilach Baumer
Israel-based Anima will receive an upfront payment of $30 million and $14 million for research, but could potentially get as much as $1.05 billion in milestones
